World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2027)

The World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2027) explores advances in osteoporosis and musculoskeletal disease research, clinical management, aging, fracture prevention, and emerging therapeutic and AI-driven approaches.

Key Topics

• Novel drug development for osteoporosis
• Mechanisms of musculoskeletal aging and interventions
• CKD-related osteoporosis and clinical practice
• Fracture risk assessment in neurological comorbidities
• Pregnancy, lactation, and osteoporosis
• Safe discontinuation of Denosumab
• Nutrition and exercise for musculoskeletal health
• AI-facilitated management of musculoskeletal diseases
• Bone oncology and prevention of skeletal-related events
• Diagnosis of rare bone diseases beyond DXA
• Cardiovascular risk assessment in osteoporosis management
• Osteoporosis treatment pathways in lower- and middle-income countries
• Diabetes and fracture risk
• Orthopedic fracture management

Who should attend

• Clinicians treating osteoporosis and musculoskeletal diseases
• Researchers in bone and musculoskeletal health
• Orthopedic specialists
• Endocrinologists
• Geriatric medicine professionals
• Rheumatology professionals
• Healthcare professionals interested in bone health and fracture prevention